Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

This study will be carried out under the guidance of professional doctor, patients with PCOS will be treated with Sitagliptin or BeiDouGen capsule or both two to assess their ovarian function and reproductive outcomes, and compare the effect of different treatment methods, which will provide the basis for PCOS intervention strategy and related research

Trial Details

NCT ID
NCT06587698
Phase
NA
Sponsor
Peking University Third Hospital
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Sitagliptin
  • BeiDouGen
  • Sitagliptin+BeiDouGen
Locations (sample)
  • Beijing, Beijing Municipality, China|39.9075,116.39723

Key Eligibility Criteria

  • Female patients aged 20-40 years who plan to conceive or are infertile in our center.
  • Diagnosed with PCOS according to the Rotterdam criteria: Diagnosis of PCOS can be made if two out of the following three criteria are met: (1) Olig…
  • Patients who are regularly followed up at our clinic. No participation in other research projects currently or in the past 3 months.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →